Skip to main content
. 2022 Apr 30;3:13. doi: 10.21037/tbcr-22-21

Table 7. Recommendations of intensive adjuvant therapy for HER2 positive breast cancer.

Stratification Level I recommendations Level II recommendations
Positive lymph nodes and after adjuvant therapy with H Sequential neratinib (1A)
Positive lymph nodes and after adjuvant therapy with HP Sequential neratinib (2A)

H, trastuzumab; P, pertuzumab.